Skip to main content

Table 1 Clinicopathological features of 46 Xp11.2 RCC patients

From: Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas

Clinicopathological features

n (%)

Age (yr)

 

 < 65/ ≥ 65

40 /6

 Median (range)

39 (15–72)

Gender

 

 Male/female

19/27

Tumor location

 

 Left/right

27/19

Tumor size (max diameter, cmmm)

 

 Mean ± SD

41.29 ± 19.08

Symptoms (%)

 

 Lumbar pain

4 (8.9)

 Pelvic pain

1 (2.1)

 Hematuria

4 (8.9)

T classification

 

 T1a/T1b

13/8

 T2a/T2b

3/0

 T3

3

 T4

0

Lymph node metastasis

 

 N0/N1

44/2

Distal metastasis

 

 M0/M1

43/3

Operation

 

 Radical nephrectomy

13

 Partial nephrectomy

30

 Cytoreduction surgery

3

Follow-up

 

 Median OS (mo)

30.0

 Dead/alive/lost

4/36/6

 Median CSS (mo)

24.0

  1. OS Overall survival; CSS Cancer specific survival